Nutritional High International Inc. is pleased to announce its Sacramento facility has received its provisional distribution license from the State.
Nutritional High International Inc. (“Nutritional High” or the “Company”) (CSE:EAT, OTCQB:SPLIF, FRANKFURT:2NU) is pleased to announce its Sacramento facility has received its provisional distribution license from the State. The facility will commence distribution operations upon receipt of its local permit.
“Last year we outlined our distribution strategy in California. This license is another step towards our goal of becoming the largest distributor of cannabis products in the State,” commented Adam Szweras, Co-Chairman of Nutritional High. “The Sacramento facility, together with our Oakland and Chatsworth hubs, forms the backbone of our distribution architecture in California and allows us to expand the reach of our brand portfolio.”
According to GreenWave Advisors, legal cannabis sales in California are expected to grow from approximately $2B in 2018 to $6.5B by 2022. The number of licensed dispensaries grew from ~450 in Q3 ’18 to 650 in Q4 ’18, but penetration remains low compared to Colorado where there are 540 retail licensees with a population of just 5.6 million.
“Our statewide facility architecture is designed not just to service today’s 600 stores, but the 1000-to-2000 or more dispensaries we expect in California within just a few years,” said Dakota Sullivan, CEO of Calyx Brands. “Having our main warehouses located on key transportation arteries in Sacramento and Chatsworth allows us to move product from growers and manufacturers all over the State into our supply chain quickly and with less cost. By plugging in flexible shipping hubs such as our Oakland facility as well as Chatsworth that are in the heart of the fastest growing markets in Northern and Southern California, we’re able to deliver to dispensaries faster and more frequently for more brands, simplifying life and reducing storage demands for retailers.”
About Nutritional High International Inc.
Nutritional High is focused on developing, manufacturing and distributing products under recognized brands in the cannabis products industry, with a specific focus on edibles and oil extracts for medical and adult recreational use. The Company works exclusively with licensed facilities in jurisdictions where such activity is permitted and regulated by state law.
The Company follows a vertically integrated model with a fully developed strategy for acquisitions in extraction, production, sales, and distribution sectors of the cannabis industry. Nutritional High has brought its flagship FLÏ™ edibles and extracts product line from production to market through its wholly owned subsidiaries in California and Oregon, as well as Colorado where its FLÏ™ products are manufactured by a third-party licensed producer. In California, the Company distributes its products and products manufactured by other leading producers through its wholly owned distributor Calyx Brands Inc. and is entering the Nevada, Washington State and Canadian markets in the near future.
For updates on the Company’s activities and highlights of the Company’s press releases and other media coverage, please follow Nutritional High on Facebook, Twitter and Instagram or visit www.nutritionalhigh.com.
For further information, please contact:
Co-Chairman of the Board
Nutritional High International Inc.
Director, Investor Relations
Nutritional High International Inc.
NEITHER THE CANADIAN SECURITIES EXCHANGE NOR OTC MARKETS GROUP INC., NOR THEIR REGULATIONS SERVICES PROVIDERS HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
This news release may contain forward-looking statements and information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Risks that may have an impact on the ability for these events to be achieved include completion of due diligence, negotiation of definitive agreements and receipt of applicable approvals. Although such statements are based on management’s reasonable assumptions, there can be no assurance that such assumptions will prove to be correct. We assume no responsibility to update or revise them to reflect new events or circumstances.
The Company’s securities have not been registered under the U.S. Securities Act of 1933, as amended (the “U.S. Securities Act”), or applicable state securities laws, and may not be offered or sold to, or for the account or benefit of, persons in the United States or “U.S. Persons”, as such term is defined in Regulation S under the U.S. Securities Act, absent registration or an applicable exemption from such registration requirements. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in the United States or any jurisdiction in which such offer, solicitation or sale would be unlawful.
Additionally, there are known and unknown risk factors which could cause the Company’s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information contained herein. All forward-looking information herein is qualified in its entirety by this cautionary statement, and the Company disclaims any obligation to revise or update any such forward-looking information or to publicly announce the result of any revisions to any of the forward-looking information contained herein to reflect future results, events or developments, except as required by law. Some of the risks and other factors that could cause actual results to differ materially from those expressed in forward-looking information expressed in this press release include, but are not limited to: obtaining and maintaining regulatory approvals including acquiring and renewing U.S. state, local or other licenses, the uncertainty of existing protection from U.S. federal or other prosecution, regulatory or political change such as changes in applicable laws and regulations, including U.S. state-law legalization, market and general economic conditions of the cannabis sector or otherwise.